ArticleCancer immunology, immunotherapy : CII2026

Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy.

Angelo Gámez-Pozo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.